CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+8.6%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.21B
AUM Growth
+$1.21B
(+16%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
9.69%
Top 10 Holdings %
Top 10 Hldgs %
50.31%
Holding
47
New
8
Increased
17
Reduced
6
Closed
7
Top Buys
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$43.9M |
| 2 |
Viatris
VTRS
|
$38.7M |
| 3 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$26.9M |
| 4 |
GHDX
Genomic Health, Inc.
GHDX
|
$26.7M |
| 5 |
WW
WW International
WW
|
$17.1M |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$41.2M |
| 2 |
Tenet Healthcare
THC
|
$37.6M |
| 3 |
Hologic
HOLX
|
$32.3M |
| 4 |
UnitedHealth
UNH
|
$24.6M |
| 5 |
Abbott
ABT
|
$23.1M |
Sector Composition
| 1 | Healthcare | 78.92% |
| 2 | Consumer Discretionary | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $91.7M | 6.01% | 1,750,000 +100,000 | +6% | +$5.24M |
|
2
Elevance Health
ELV
$71.8B
| $75.3M | 4.94% | 700,000 -100,000 | -13% | -$10.8M |
|
3
Quest Diagnostics
DGX
$20.3B
| $64.6M | 4.23% | 1,100,000 | – | – |
|
4
Community Health Systems
CYH
$387M
| $63M | 4.13% | 1,387,900 +137,900 | +11% | +$6.26M |
|
5
CONMED
CNMD
$1.68B
| $61.1M | 4.01% | 1,385,000 | – | – |
|
|
VOLC
6
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $55.5M | 3.63% | 3,150,000 +700,000 | +29% | +$12.3M |
|
|
7
Viatris
VTRS
$12.3B
| $51.6M | 3.38% | 1,000,000 +750,000 | +300% | +$38.7M |
|
8
HCA Healthcare
HCA
$94.5B
| $50.7M | 3.32% | 900,000 +100,000 | +13% | +$5.64M |
|
|
GHDX
9
DELISTED
Genomic Health, Inc.
GHDX
| $47.3M | 3.1% | 1,725,000 +975,000 | +130% | +$26.7M |
|
|
KERX
10
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $46.1M | 3.02% | 3,000,000 +1,750,000 | +140% | +$26.9M |
|
|
ACHN
11
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $43.9M | 2.88% | +5,800,000 | New | +$43.9M |
|
12
Masimo
MASI
$7.59B
| $43M | 2.81% | 1,820,000 +545,000 | +43% | +$12.9M |
|
|
13
Tenet Healthcare
THC
$16.3B
| $42.2M | 2.77% | 900,000 -800,000 | -47% | -$37.6M |
|
14
Labcorp
LH
$23.1B
| $41M | 2.68% | 400,000 +25,000 | +7% | +$2.56M |
|
|
HRC
15
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $37.1M | 2.43% | 893,223 +293,223 | +49% | +$12.2M |
|
16
Haemonetics
HAE
$2.63B
| $35.3M | 2.31% | 1,000,000 -202,000 | -17% | -$7.13M |
|
|
UAM
17
DELISTED
Universal American Corp
UAM
| $34.8M | 2.28% | 4,178,259 | – | – |
|
|
ARIA
18
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $31.9M | 2.09% | 5,000,000 +2,000,000 | +67% | +$12.7M |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $25.3M | 1.66% | 656,900 -50,000 | -7% | -$1.93M |
|
|
SQNM
20
DELISTED
SEQUENOM INC NEW
SQNM
| $24.4M | 1.6% | 6,300,000 +3,388,480 | +116% | +$13.1M |
|
21
Novavax
NVAX
$1.21B
| $21.9M | 1.44% | 4,750,000 +2,500,000 | +111% | +$11.6M |
|
|
RVNC
22
DELISTED
Revance Therapeutics, Inc.
RVNC
| $21.4M | 1.4% | 630,000 +330,000 | +110% | +$11.2M |
|
|
FURX
23
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $21.2M | 1.39% | 200,000 +50,000 | +33% | +$5.31M |
|
|
AMRN
24
Amarin Corp
AMRN
$311M
| $19.4M | 1.27% | 11,000,000 | – | – |
|
|
WW
25
DELISTED
WW International
WW
| $17.1M | 1.12% | +850,000 | New | +$17.1M |
|